
Thermo Fisher Scientific TAPBPL Monoclonal Antibody (OTI5D7), TrueMAB
TAPBPL 단백질을 인식하는 Mouse IgG1 단클론 항체로, Western blot과 IHC(Paraffin)에서 검증됨. HEK293T 세포에서 발현된 full-length human TAPBPL 항원을 면역원으로 사용. 동결건조 형태로 제공되며, 재구성 시 약 1 mg/mL 농도로 사용 가능. 연구용으로만 사용.
- 카탈로그번호
- CF505551
- 판매단위
- pk
카탈로그
1개 옵션 · 카탈로그 번호를 클릭하면 복사됩니다Thermo Fisher Scientific · Thermo Fisher Scientific TAPBPL Monoclonal Antibody (OTI5D7), TrueMAB
Applications and Tested Dilutions
| Application | Tested Dilution |
|---|---|
| Western Blot (WB) | 1:2,000 |
| Immunohistochemistry (Paraffin) (IHC (P)) | 1:150 |
Product Specifications
| 항목 | 내용 |
|---|---|
| Species Reactivity | Human |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Clone | OTI5D7 |
| Immunogen | Full length human recombinant protein of human TAPBPL produced in HEK293T cell. |
| Conjugate | Unconjugated |
| Form | Lyophilized |
| Concentration | 1 mg/mL |
| Purification | Affinity chromatography |
| Storage buffer | PBS, pH 7.3, with 8% trehalose |
| Contains | No preservative |
| Storage conditions | -20°C, Avoid Freeze/Thaw Cycles |
| Shipping conditions | Ambient (domestic); Wet ice (international) |
Product Specific Information
For reconstitution, add 100 µL distilled water to obtain a final antibody concentration of approximately 1 mg/mL.
For conjugation experiments, perform an additional desalting step using Zeba Spin Desalting Columns (7K MWCO, 0.5 mL, Product #89882).
Target Information
Tapasin (TAPBP) is a member of the variable-constant Ig superfamily that links MHC class I molecules to the transporter associated with antigen processing (TAP) in the endoplasmic reticulum.
The TAPBP gene is located near the MHC complex on chromosome 6p21.3.
TAPBPL, a related member of the Ig superfamily, is localized on chromosome 12p13.3, a region somewhat paralogous to the MHC.
For Research Use Only.
Not for use in diagnostic procedures. Not for resale without express authorization.
Thermo Fisher Scientific 상품 둘러보기
전체보기문의
0개 · 배송·재고 문의는 실시간 상담이 빠릅니다아직 등록된 문의가 없어요.
